Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-20-000643
Filing Date
2020-05-27
Accepted
2020-05-27 21:47:07
Documents
1
Period of Report
2020-05-20

Document Format Files

Seq Description Document Type Size
1 e619670_4-xoma.html 4  
1 e619670_4-xoma.xml 4 9811
  Complete submission text file 0001193805-20-000643.txt   11302
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE SANSOME STREET 30TH FLOOR SAN FRANCISCO CA 94104
Business Address
PERRY MATTHEW D (Reporting) CIK: 0001454337 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 20916806